Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 31 (MTND4LP31)

Target
MTND4LP31
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND4L pseudogene 31 (MTND4LP31) is a nonfunctional genomic sequence related to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L gene (MT-ND4L). As a pseudogene, it does not code for any protein product and has no established biological or pathological role. There is no evidence supporting its use as a therapeutic target, biomarker, or clinical safety concern, and it is not associated with drug interactions or mechanisms of action. Pseudogenes such as MTND4LP31 are generally considered genomic relics resulting from the duplication or retrotransposition of functional gene sequences; they are neither expressed nor active in normal cellular physiology[6]. Summary: MT-ND4L pseudogene 31 (MTND4LP31) is a pseudogene and not a valid drug target, enzyme, receptor, or transporter. It is not implicated in disease, therapy, or any biological process, and there is something “incorrect” about considering it as a therapeutic target. The functional gene MT-ND4L has well-established mitochondrial roles, but pseudogenes do not share these properties[1][2][3][4][6].

Other names
MT-ND4L pseudogene 31MTND4LP31mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 31

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 31 (MTND4LP31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 31 (MTND4LP31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call